Cutaneous Lymphoid Hyperplasia Treated With Rituximab: Report of 4 Patients



Matin M¹ ; Asilian A¹ ; Mozafarpoor S¹ ; Haftbaradaran E²
Source: Journal of Isfahan Medical School Published:2016

Abstract

Background: Cutaneous benign lymphoid hyperplasia (CLH) is a B-cell pseudolymphoma of unknown origin and the most involving site is the face. Case Report: This report presents 4 CLH patients treated with rituximab. Conclusion: Rituximab may be useful for resistant or relapsing forms of CLH who failed other forms of therapy. © 2016. Isfahan University of Medical Sciences(IUMS). All rights reserved.